Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not listed as causing photosensitivity in its UK SmPC, and the medicine itself does not chemically sensitise your skin to sunlight. That said, several real and indirect effects of treatment mean sun exposure deserves a little more thought while you're on it. This is a question our prescribers hear most weeks, and it's worth a thorough answer. As a prescription-only medicine, Mounjaro requires clinical assessment before anyone starts it — a prescriber reviews your full picture before any pen is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The starting point for any question like this is the Mounjaro SmPC — the document Eli Lilly submitted to the MHRA for UK approval. Photosensitivity, phototoxicity and sunburn are not listed adverse reactions. The NHS medicines page for tirzepatide likewise does not flag sun sensitivity as a known side effect. So if you have read online that Mounjaro makes your skin burn, the short answer is that this is not supported by the licensed product data.
That does not mean every physical change people notice in the sun while taking Mounjaro is imagined. It means the mechanism is indirect rather than the drug itself acting on your photoreceptors, and our page on Mounjaro and the sun walks through what that distinction means in practice.
Injection-site reactions (redness, mild bruising, warmth) are listed in the SmPC as common. If you inject into your abdomen and then spend an afternoon in direct sun, that patch of skin can become more uncomfortable. Rotating your injection site and keeping it covered in strong sunlight is a simple precaution. Read more about the full side-effect picture on our tirzepatide overview page.
Several things happen during Mounjaro treatment that can change how you experience heat and sun, even though the molecule itself is not to blame.
Reduced calorie intake is one. Many people eat considerably less once tirzepatide suppresses appetite. A lower intake of antioxidant-rich foods (fruit, vegetables, foods containing vitamins C and E) may modestly reduce the skin's natural resilience to UV over time, though this effect is subtle and not specific to Mounjaro. Staying well-nourished matters.
Fluid intake is another consideration. Nausea and reduced appetite can lead to lower hydration, and dehydrated skin is more prone to heat discomfort. The NHS tirzepatide guidance recommends seeking medical advice if gastrointestinal side effects cause significant fluid loss. Drinking enough water (especially in warm weather) is part of looking after yourself on treatment.
Fatigue, listed as a common side effect, can also make heat harder to tolerate. That's a different thing from burning, but the two can blur if you feel rough in the sun and are trying to work out why, so it is worth reading our dedicated page on whether Mounjaro makes you more sensitive to the sun before drawing conclusions.
A separate question (whether Mounjaro raises your body temperature or makes you feel physically hot) is explored in detail on our page about Mounjaro and body temperature changes.
Most people who notice any skin change on Mounjaro find it is mild and linked to the injection site or to a GI side effect settling in. But some reactions do warrant a call to a clinician.
Contact your GP or prescriber promptly if you develop a widespread rash, blistering, hives or any skin change that looks like an allergic reaction. Signs of a serious allergic response (swelling of the face, lips or throat, difficulty breathing, rapid heartbeat) need emergency care. Do not wait to report these.
The MHRA's Yellow Card scheme exists for exactly this reason: if you suspect a medicine is causing something unexpected, including an unusual skin reaction, you can report it at yellowcard.mhra.gov.uk. Your report contributes to ongoing post-market safety monitoring for tirzepatide, which carries a Black Triangle (▼) status in the UK, indicating it is subject to additional scrutiny.
For broader context on whether tirzepatide does things beyond what people expect (including questions about fat metabolism) the page on how Mounjaro affects fat covers the mechanism clearly.
Given the indirect effects above, a few straightforward habits make sense during summer or in hot climates.
Use SPF 30 or higher daily, regardless of Mounjaro, this is good advice for most adults in the UK and is not a Mounjaro-specific precaution. Keep injection sites covered or shaded for at least a few hours after injecting if you plan to be outside. Stay hydrated: the MHRA's guidance on GLP-1 medicines emphasises fluid replacement if GI symptoms reduce your intake. Eat enough protein and varied vegetables to support skin health alongside the reduced appetite that treatment brings.
If you're planning a holiday involving significant heat or prolonged sun exposure and you have questions about managing your pen storage or timing, our frequently asked questions cover practical storage guidance, and our team is reachable through our contact page seven days a week. Pens must be kept refrigerated until use, a detail worth planning around when travelling.
If you're weighing up how Mounjaro compares with other treatment options, our weight-loss treatment overview is a useful starting point. And if you're ready to find out whether you're clinically suitable, start your free consultation, a GPhC-registered prescriber, not a system, reviews every application the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.